Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.

被引：0
|
作者：
Richardson, PG
Soiffer, RJ
Antin, JH
Jin, Z
Kurtzberg, J
Martin, PL
Hockenbery, D
Murray, KF
Vogelsang, GB
Chen, A
Krishnan, A
Kernan, NA
Avigan, D
Spitzer, TR
Warren, D
Momtaz, P
Revta, C
Wei, LJ
Iacobelli, M
McDonald, GB
Guinan, EC
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dana Farber Canc Inst,BIDMC,Childrens Hosp, Boston, MA USA
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Columbia Univ, New York, NY 10027 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
399
引用
收藏
页码：120A / 120A
页数：1
相关论文
共 36 条
  • [1] Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.
    Richardson, P
    Soiffer, RJ
    Antin, JH
    Jin, Z
    Vredenburgh, JJ
    Kurtzberg, J
    Martin, PL
    Hockenbery, D
    Steinbach, G
    Murray, KF
    Vogelsang, GB
    Chen, A
    Krishnan, A
    Prasad, VK
    Warren, DL
    Momtaz, P
    Batchelder, A
    Wei, LJ
    Rifai, N
    Bradwin, G
    Iacobelli, M
    McDonald, GB
    Guinan, EC
    BLOOD, 2003, 102 (11) : 193A - 193A
  • [2] Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT).
    Richardson, PG
    Soiffer, R
    Antin, JH
    Vredenburgh, J
    Kurtzberg, J
    Martin, PL
    Hockenbery, D
    Steinbach, G
    Murray, K
    Vogelsang, G
    Chen, A
    Warren, DL
    Momtaz, P
    Wei, LJ
    Jin, Z
    Rifai, N
    Bradwin, G
    Iacobelli, M
    McDonald, GB
    Guinan, EC
    BLOOD, 2002, 100 (11) : 112A - 112A
  • [3] Defibrotide (DF) for the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post SCT: Final results of a phase II, multicenter, randomized study and preliminary analyses of surrogate markers and ultrasound findings
    Richardson, PG
    Soiffer, RJ
    Antin, JH
    Voss, SD
    Jin, Z
    Kurtzberg, J
    Martin, PL
    Hockenbery, D
    Murray, KF
    Vogelsang, GB
    Chen, A
    Krishnan, A
    Kernan, NA
    Avigan, D
    Spitzer, TR
    Iannone, R
    Giralt, S
    Warren, D
    Momtaz, P
    Bradwin, G
    Iacobelli, M
    McDonald, GB
    Guinan, EC
    BLOOD, 2004, 104 (11) : 103A - 104A
  • [4] Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol
    Richardson, Paul
    Smith, Angela
    Arai, Sally
    Grupp, Stephan A.
    Kernan, Nancy A.
    Adams, Roberta
    Martin, Paul L.
    Abhyankar, Sunil
    Gillio, Alfred, III
    Grimley, Michael
    Lehmann, Leslie E.
    Haut, Paul
    Termuhlen, Amanda
    Antin, Joseph H.
    Spitzer, Thomas
    Avigan, David
    Massaro, Joseph
    Hannah, Alison L.
    Iacobelli, Massimo
    Soiffer, Robert J.
    BLOOD, 2010, 116 (21) : 399 - 400
  • [5] Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC)
    Richardson, Paul G.
    Steinbach, Gideon
    Kernan, Nancy
    Guinan, Eva C.
    Chen, Allen R.
    Martin, Paul L.
    Krishnan, Amrita
    Arai, Sally
    Brochstein, Joel A.
    Grupp, Stephan A.
    Mineishi, Shin
    Termuhlen, Amanda
    Tomblyn, Marcie
    Antin, Joseph H.
    Revta, Carolyn
    Hume, Robin
    Massaro, Joseph
    Hannah, Alison L.
    Iacobelli, Massimo
    Soiffer, Robert J.
    BLOOD, 2010, 116 (21) : 1430 - 1431
  • [6] Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control
    Richardson, Paul
    Tomblyn, Marcie
    Kernan, Nancy
    Brochstein, Joel A.
    Mineishi, Shin
    Termuhlen, Amanda
    Arai, Sally
    Grupp, Stephan A.
    Guinan, Eva
    Martin, Paul L.
    Corbacioglu, Selim
    Holler, Ernst
    D'Agostino, Ralph
    Massaro, Joseph
    Hannah, Alison L.
    Iacobelli, Massimo
    Soiffer, Robert J.
    BLOOD, 2009, 114 (22) : 272 - 273
  • [7] Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.
    Richardson, Paul
    Soiffer, R. J.
    Antin, J. H.
    Jin, Z.
    Kurtzberg, J.
    Martin, P. L.
    Steinbach, G.
    Murray, K. F.
    Vogelsang, G. B.
    Chen, A.
    Krishnan, A.
    Kernan, N. A.
    Avigan, D.
    Spitzer, T. R.
    Warren, D.
    Revta, C.
    Wei, L. J.
    Iacobelli, M.
    McDonald, G. B.
    Guinan, E. C.
    BLOOD, 2006, 108 (11) : 17A - 18A
  • [8] Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population.
    Richardson, PG
    Warren, DL
    Momtaz, P
    Soiffer, R
    Antin, JH
    Spitzer, T
    Avigan, D
    Wei, LJ
    Jin, Z
    Rifai, N
    Bradwin, G
    Vredenburgh, J
    Kurtzberg, J
    Martin, PL
    Vogelsang, G
    Arai, S
    Chen, A
    McDonald, GB
    Murray, K
    Iacobelli, M
    Guinan, EC
    BLOOD, 2001, 98 (11) : 853A - 853A
  • [9] Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
    Richardson, Paul G.
    Riches, Marcie L.
    Kernan, Nancy A.
    Brochstein, Joel A.
    Mineishi, Shin
    Termuhlen, Amanda M.
    Arai, Sally
    Grupp, Stephan A.
    Guinan, Eva C.
    Martin, Paul L.
    Steinbach, Gideon
    Krishnan, Amrita
    Nemecek, Eneida R.
    Giralt, Sergio
    Rodriguez, Tulio
    Duerst, Reggie
    Doyle, John
    Antin, Joseph H.
    Smith, Angela
    Lehmann, Leslie
    Champlin, Richard
    Gillio, Alfred
    Bajwa, Rajinder
    D'Agostino, Ralph B., Sr.
    Massaro, Joseph
    Warren, Diane
    Miloslavsky, Maja
    Hume, Robin L.
    Iacobelli, Massimo
    Nejadnik, Bijan
    Hannah, Alison L.
    Soiffer, Robert J.
    BLOOD, 2016, 127 (13) : 1656 - 1665
  • [10] Multi-institutional emergency use of defibrotide (DF) in 75 pts post SCT with severe VOD and multi-system organ failure (MOF): Response without significant toxicity in a high risk population.
    Richardson, PG
    Murakami, C
    Warren, DL
    Jin, Z
    Neuberg, D
    Elias, AD
    Antin, J
    Soiffer, R
    Bearman, SI
    Vredenburgh, J
    Vogelsang, G
    Hoppensteadt, D
    Fareed, J
    Iacobelli, M
    McDonald, GB
    Guinan, EC
    BLOOD, 2000, 96 (11) : 585A - +
1234